Coffee intake reduces heart disease risk

Moderate intake leads to 25 per cent reduced chance of developing Type 2 Diabetes


Ians June 25, 2015
Lowest Cardio Vascular Disease mortality risk is seen at an intake of approximately three cups of coffee per day. PHOTO: FILE

LONDON: Drinking three to five cups of coffee per day could cut an individual’s cardiovascular disease (CVD) mortality risk by up to 21 per cent, says new research.

“It is important to acknowledge factors which might have a protective effect against CVD mortality. Moderate coffee consumption could play a significant role in reducing CVD mortality risk, which would impact health outcomes and healthcare spending across Europe,” said Professor Doutor AntAnio Vaz Carneiro of the Faculdade de Medicine da Universidade de Lisboa, Portugal.

The report published by the Institute for Scientific Information on Coffee (ISIC) highlights the role of lifestyle factors in CVD mortality risk reduction, the epidemiological evidence on coffee and CVD mortality.

The lowest CVD mortality risk is seen at an intake of approximately three cups of coffee per day, with a percentage risk reduction of up to 21 per cent.

Drinking three to four cups of coffee per day is linked with an approximate 25 per cent lower risk of developing type 2 diabetes compared to consuming none or less than two cups per day. People with diabetes typically have a higher CVD mortality risk, therefore this association may be linked to a decreased CVD risk.

Half of CVD cases in women could be avoided by modifying lifestyle choices, as approximately 73 per cent of coronary heart disease cases and 46 per cent of clinical CVD are attributable to an unhealthy lifestyle. 

Published in The Express Tribune, June 26th, 2015.

Like Life & Style on Facebook, follow @ETLifeandStyle on Twitter for the latest in fashion, gossip and entertainment.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ

E-Publications

Most Read